Advisors Capital Management’s West Pharmaceutical WST Stock Holding History

Advisors Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Hold	4,270	–	–	0.02%	306
2026 Q1	$1.07M	Sell	4,270 -237	-5%	-$59K	0.01%	313
2025 Q4	$1.24M	Hold	4,507	–	–	0.01%	303
2025 Q3	$1.18M	Buy	4,507 +237	+6%	+$57.6K	0.01%	299
2025 Q2	$934K	Buy	4,270 +4	+0.1%	+$855	0.01%	305
2025 Q1	$955K	Sell	4,266 -3	-0.1%	-$827	0.01%	293
2024 Q4	$1.4M	Buy	4,269 +19	+0.4%	+$5.98K	0.02%	270
2024 Q3	$1.28M	Sell	4,250 -12	-0.3%	-$3.67K	0.02%	273
2024 Q2	$1.4M	Sell	4,262 -22	-0.5%	-$7.78K	0.02%	266
2024 Q1	$1.7M	Buy	+4,284	New	+$1.58M	0.03%	257

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Advisors Capital Management's WST Position: Q2 2026 in Review

Advisors Capital Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 4,270 shares worth $1.53M. The position accounts for 0.02% of the portfolio, ranked #306.

Advisors Capital Management first reported a position in WST in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.7M in Q1 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Advisors Capital Management held 4,270 shares of West Pharmaceutical worth $1.53M as of Q2 2026.
Advisors Capital Management left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.02% of Advisors Capital Management's portfolio in Q2 2026, its #306 holding.
Advisors Capital Management first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
Advisors Capital Management's West Pharmaceutical position peaked at $1.7M in Q1 2024.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.